McGill University has joined Moderna’s mRNA Access program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through collaborative research and preclinical development. McGill is the first university in Canada to join this program as it ramps up its international rollout.
Category:
Published on: 25 Mar 2022
McGill University has joined Moderna’s mRNA Access program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through collaborative research and preclinical development. McGill is the first university in Canada to join this program as it ramps up its international rollout.
Category:
Published on: 25 Mar 2022
Dr. Madhukar Pai, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and past McGill Global Health Programs Director, co-authored a recent Science Editorial.
Category:
Published on: 30 Nov 2021
McGill University professor Nicole Basta and her team have created an interactive online COVID-19 vaccine tracker, that provides real-time updates on progress in developing a safe and effective vaccine.
Published on: 26 Oct 2020
Sexual behaviour of teenage girls does not appear to have been affected by routine human papilloma virus (HPV) vaccination, according to a large study published in CMAJ (Canadian Medical Association Journal).
Category:
Published on: 8 Dec 2014
